Cargando…
MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732465/ https://www.ncbi.nlm.nih.gov/pubmed/29246135 http://dx.doi.org/10.1186/s12906-017-2036-1 |
_version_ | 1783286704205987840 |
---|---|
author | Hwang, Ji Hye Kang, Seok Yong Kang, An Na Jung, Hyo Won Jung, Chul Jeong, Jin-Ho Park, Yong-Ki |
author_facet | Hwang, Ji Hye Kang, Seok Yong Kang, An Na Jung, Hyo Won Jung, Chul Jeong, Jin-Ho Park, Yong-Ki |
author_sort | Hwang, Ji Hye |
collection | PubMed |
description | BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. RESULTS: The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. CONCLUSIONS: These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain. |
format | Online Article Text |
id | pubmed-5732465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57324652017-12-21 MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel Hwang, Ji Hye Kang, Seok Yong Kang, An Na Jung, Hyo Won Jung, Chul Jeong, Jin-Ho Park, Yong-Ki BMC Complement Altern Med Research Article BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. RESULTS: The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. CONCLUSIONS: These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain. BioMed Central 2017-12-15 /pmc/articles/PMC5732465/ /pubmed/29246135 http://dx.doi.org/10.1186/s12906-017-2036-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hwang, Ji Hye Kang, Seok Yong Kang, An Na Jung, Hyo Won Jung, Chul Jeong, Jin-Ho Park, Yong-Ki MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title | MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title_full | MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title_fullStr | MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title_full_unstemmed | MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title_short | MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel |
title_sort | mok, a pharmacopuncture medicine, regulates thyroid dysfunction in l-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the trpv1 ion channel |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732465/ https://www.ncbi.nlm.nih.gov/pubmed/29246135 http://dx.doi.org/10.1186/s12906-017-2036-1 |
work_keys_str_mv | AT hwangjihye mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT kangseokyong mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT kanganna mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT junghyowon mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT jungchul mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT jeongjinho mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel AT parkyongki mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel |